Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2022-08-12 Investor Presentation
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
111年08月法人說明會簡報 — 179520220812E002.pdf
Investor Presentation Classification · 95% confidence The document is titled 'SECOND QUARTER 2022 RESULTS' and is described as an 'Investor Presentation' dated August 2022. It contains detailed business highlights, financial results, strategic deliverables, and pipeline development information for Q2 2022. The content includes forward-looking statements, financial metrics such as sales, gross margin, operating margin, EPS, and detailed breakdowns of revenue by market and therapeutic area. It also discusses strategic initiatives and product pipeline updates. The document length is 13,873 characters, indicating it is a full presentation rather than a brief announcement. The presence of detailed financial results and strategic information aimed at investors aligns with the definition of an Investor Presentation (IP). It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER) since it is a presentation format with a mix of financial and strategic content. Therefore, the most appropriate classification is Investor Presentation (IP).
2022-08-12 Chinese
111年08月法人說明會簡報 — 179520220812M002.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation of the company's Q2 2022 operational and financial performance, including revenue, profit margins, market expansion, product portfolio, and R&D progress. It contains comprehensive financial data such as net sales, gross profits, operating income, EPS, and segment performance. The document is titled as a Q2'22 operational results report and investor briefing, indicating it is a quarterly report with substantive financial data and management commentary. It is not a brief announcement or a certification letter, nor is it a full annual report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2022
2022-08-12 Chinese
111年08月法人說明會簡報 — 179520220812E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'SECOND QUARTER 2022 RESULTS' and is described as an 'Investor Presentation' dated August 2022. It contains detailed business highlights, financial results, strategic deliverables, and pipeline development information for Q2 2022. The content includes sales figures, margin analysis, market leadership data, and future outlook, which are typical components of an investor presentation. The document length is about 13,873 characters, which is consistent with a detailed presentation rather than a brief announcement or a full annual or quarterly report. There is no indication that this is a transcript, audit report, or regulatory filing. Therefore, the document fits best into the 'Investor Presentation' category (IP).
2022-08-12 Chinese
111年08月法人說明會簡報 — 179520220812M001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation of the company's Q2 2022 operational and financial performance, including revenue, profit margins, market share, product development, and strategic initiatives. It contains comprehensive financial data such as net sales, gross profits, operating income, EPS, and segment performance. The document also includes forward-looking statements, management confidence, and detailed business updates. The length is over 11,000 characters, indicating it is not a brief announcement. The content aligns with a quarterly or interim financial report rather than a simple earnings release or investor presentation. Therefore, the document fits the definition of an Interim / Quarterly Report (IR), as it provides substantive financial data and analysis for a period shorter than a full fiscal year (Q2 2022). Q2 2022
2022-08-12 Chinese
111年08月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing of scheduled investor presentations (法人說明會) with details such as dates, times, locations, and links to presentation materials. It includes references to financial and operational status explanations to investors, typical of investor presentations. The document length is short (1166 characters) and it does not contain actual financial statements or detailed financial analysis. It is not an announcement of a report publication but rather a schedule and summary of investor presentations. Therefore, the most appropriate classification is Investor Presentation (IP).
2022-08-12 Chinese
111年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically related to changes in equity, including items such as common stock, capital surplus, legal surplus reserves, special surplus reserves, undistributed earnings, retained earnings, and other equity components. The data is presented for the current half-year period (民國111年上半年度) and the same period last year, indicating a focus on interim financial information. The presence of comprehensive financial tables with actual figures and accounting items confirms this is a substantive financial report rather than a brief announcement or certification. The document length is 4498 characters, which is sufficient to contain detailed financial data. The content aligns with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes substantive financial data and analysis. There is no indication that this is an Annual Report (10-K), Audit Report (AR), or other categories such as Earnings Release or Regulatory Filing. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-08-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.